These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10791864)

  • 1. Working memory functioning in medicated Parkinson's disease patients and the effect of withdrawal of dopaminergic medication.
    Fournet N; Moreaud O; Roulin JL; Naegele B; Pellat J
    Neuropsychology; 2000 Apr; 14(2):247-53. PubMed ID: 10791864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine asymmetry interacts with medication to affect cognition in Parkinson's disease.
    Tomer R; Aharon-Peretz J; Tsitrinbaum Z
    Neuropsychologia; 2007 Jan; 45(2):357-67. PubMed ID: 16876208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function.
    MacDonald AA; Monchi O; Seergobin KN; Ganjavi H; Tamjeedi R; MacDonald PA
    Mov Disord; 2013 Feb; 28(2):153-60. PubMed ID: 23165957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic effects on cognitive performance in patients with Parkinson's disease.
    Lange KW; Paul GM; Naumann M; Gsell W
    J Neural Transm Suppl; 1995; 46():423-32. PubMed ID: 8821078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Working memory in medicated patients with Parkinson's disease: the central executive seems to work.
    Fournet N; Moreaud O; Roulin JL; Naegele B; Pellat J
    J Neurol Neurosurg Psychiatry; 1996 Mar; 60(3):313-7. PubMed ID: 8609510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociable effects of dopaminergic therapy on spatial versus non-spatial working memory in Parkinson's disease.
    Mollion H; Ventre-Dominey J; Dominey PF; Broussolle E
    Neuropsychologia; 2003; 41(11):1442-51. PubMed ID: 12849762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Parkinson's disease and dopamine on digit span measures of working memory.
    Grogan JP; Knight LE; Smith L; Irigoras Izagirre N; Howat A; Knight BE; Bickerton A; Isotalus HK; Coulthard EJ
    Psychopharmacology (Berl); 2018 Dec; 235(12):3443-3450. PubMed ID: 30315362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The alpha2 agonist, clonidine, improves spatial working performance in Parkinson's disease.
    Riekkinen M; Jäkälä P; Kejonen K; Riekkinen P
    Neuroscience; 1999; 92(3):983-9. PubMed ID: 10426538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early-stage cognitive impairment in Parkinson's disease and the influence of dopamine replacement therapy.
    Miah IP; Olde Dubbelink KT; Stoffers D; Deijen JB; Berendse HW
    Eur J Neurol; 2012 Mar; 19(3):510-6. PubMed ID: 22040383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second-generation dopamine agonists and recollection impairments in Parkinson's disease.
    Shepherd TA; Edelstyn NM; Mayes AR; Ellis SJ
    J Neuropsychol; 2013 Sep; 7(2):284-305. PubMed ID: 23815454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive and motor effects of dopaminergic medication withdrawal in Parkinson's disease.
    Fern-Pollak L; Whone AL; Brooks DJ; Mehta MA
    Neuropsychologia; 2004; 42(14):1917-26. PubMed ID: 15381022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine and cognitive functioning in de novo subjects with Parkinson's disease: effects of pramipexole and pergolide on working memory.
    Costa A; Peppe A; Dell'Agnello G; Caltagirone C; Carlesimo GA
    Neuropsychologia; 2009 Apr; 47(5):1374-81. PubMed ID: 19428401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of clinical motor variables and medication dosage on working memory in Parkinson's disease.
    Moustafa AA; Bell P; Eissa AM; Hewedi DH
    Brain Cogn; 2013 Jul; 82(2):137-45. PubMed ID: 23660434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fractionating the Neurocognitive Mechanisms Underlying Working Memory: Independent Effects of Dopamine and Parkinson's Disease.
    Fallon SJ; Mattiesing RM; Muhammed K; Manohar S; Husain M
    Cereb Cortex; 2017 Dec; 27(12):5727-5738. PubMed ID: 29040416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Age-related working memory decline in patients with Parkinson's disease].
    Tamura I; Kikuchi S; Kitagawa M; Otsuki M; Tashiro K
    No To Shinkei; 2003 Apr; 55(4):335-40. PubMed ID: 12755037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the role of dopamine replacement therapy in decision-making, working memory, and reward in Parkinson's disease: does the therapy-dose matter?
    Torta DM; Castelli L; Zibetti M; Lopiano L; Geminiani G
    Brain Cogn; 2009 Nov; 71(2):84-91. PubMed ID: 19442427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition, recollection, familiarity and executive function in medicated patients with moderate Parkinson's disease.
    Edelstyn NM; Mayes AR; Condon L; Tunnicliffe M; Ellis SJ
    J Neuropsychol; 2007 Sep; 1(2):131-47. PubMed ID: 19331014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Iowa Gambling Task in Parkinson's disease: A meta-analysis on effects of disease and medication.
    Evens R; Hoefler M; Biber K; Lueken U
    Neuropsychologia; 2016 Oct; 91():163-172. PubMed ID: 27475264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot psychometric study of aberrant salience state in patients with Parkinson's disease and its association with dopamine replacement therapy.
    Poletti M; Frosini D; Pagni C; Baldacci F; Lucetti C; Del Dotto P; Ceravolo R; Bonuccelli U
    Neurol Sci; 2014 Oct; 35(10):1603-5. PubMed ID: 25012755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease.
    Lewis SJ; Slabosz A; Robbins TW; Barker RA; Owen AM
    Neuropsychologia; 2005; 43(6):823-32. PubMed ID: 15716155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.